Literature DB >> 309395

Characterization of natural killer (NK) cells and killer (K) cells in human blood: discrimination between NK and K cell activities.

R L Bolhuis, H R Schuit, A M Nooyen, C P Ronteltap.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 309395     DOI: 10.1002/eji.1830081012

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


× No keyword cloud information.
  14 in total

1.  Normal mitogen-induced suppression of the interleukin-6 (IL-6) response and its deficiency in systemic lupus erythematosus.

Authors:  R J Warrington; W J Rutherford
Journal:  J Clin Immunol       Date:  1990-01       Impact factor: 8.317

Review 2.  Natural killer activity: early days, advances, and seminal observations.

Authors:  John R Ortaldo; Robert H Wiltrout; Craig W Reynolds
Journal:  Crit Rev Oncog       Date:  2014

3.  Identification of lymphocyte subpopulations in E-RFC-enriched and E-RFC-depleted cell fractions of fresh and cryopreserved lymphocytes.

Authors:  R L Bolhuis; H R Schuit
Journal:  Clin Exp Immunol       Date:  1979-02       Impact factor: 4.330

4.  Enhancement of spontaneous killer cytotoxicity by soluble factor.

Authors:  F M Hofman; C A Spina
Journal:  Clin Exp Immunol       Date:  1980-12       Impact factor: 4.330

5.  Lymphocytes with parallel tubular structures: morphologically a distinctive subpopulation.

Authors:  J W Smit; N R Blom; M van Luyn; M R Halie
Journal:  Blut       Date:  1983-06

6.  Decrease of peripheral large granular lymphocytes in Graves' disease.

Authors:  Y Iwatani; N Amino; O Kabutomori; H Mori; H Tamaki; S Motoi; Y Izumiguchi; K Miyai
Journal:  Clin Exp Immunol       Date:  1984-01       Impact factor: 4.330

7.  In vitro augmentation of human natural cytotoxic activity.

Authors:  M R Potter; M Moore
Journal:  Clin Exp Immunol       Date:  1981-05       Impact factor: 4.330

8.  Analysis of natural killer activity and antibody-dependent cellular cytotoxicity in healthy volunteers and in patients with primary lung cancer and metastatic pulmonary tumors.

Authors:  N Saijo; E Shimizu; N Irimajiri; A Ozaki; K Kimura; T Takizawa; H Niitani
Journal:  J Cancer Res Clin Oncol       Date:  1982       Impact factor: 4.553

9.  Immune status in Crohn's disease. 4. In vitro antibody dependent cell mediated cytotoxicity in peripheral blood.

Authors:  I O Auer; E Ziemer
Journal:  Klin Wochenschr       Date:  1980-08-01

10.  Lysis of fresh human solid tumor cells by autologous lymphocytes activated in vitro by allosensitization.

Authors:  A Mazumder; E A Grimm; S A Rosenberg
Journal:  Cancer Immunol Immunother       Date:  1983       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.